ImmunityBio Investor Relations Material
Latest events
Status Update
ImmunityBio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
ImmunityBio Inc is a clinical-stage biotechnology company. We develop therapies and vaccines to treat cancers and infectious diseases. Our immunotherapy platform includes antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies and natural killer cells. We are currently completing several Phase II clinical trials for the treatment of solid and liquid tumors including bladder, pancreatic and lung cancers, as well as pathogens such as SARS-CoV-2 and HIV.
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
IBRX
Country
đșđž United States